SHEILA DINI: Open Payments
NPI 1003187709 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 14 payments from 11 companies in 2025. Trend: 2023 $381 · 2024 $494 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $71 |
| GlaxoSmithKline, LLC. | 2 | $56 |
| Blueprint Medicines Corporation | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| PharmaEssentia USA Corporation | 1 | $20 |
| ARRAY BIOPHARMA INC | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
Products named: OJJAARA, Enhertu, AYVAKIT, NINLARO, Vyloy, Nubeqa, ERLEADA, DATROWAY.
Industry payments across GA — which companies pay providers there.
